腎機能によってピペラシリン投与量を予測できるのか? 3つの異なる配列の比較
Sophie Magréault1,2, Takoua Khzouri3, Khalil Chaïbi4
1Université Sorbonne Paris Nord et Université Paris Cité, Inserm, IAME, Bobigny, France.
Therapeutic drug monitoring
|September 5, 2025
まとめ
特に腎臓のクリアランスが増加した患者では,腎機能に合わせてピペラシリンの投与量を調整する必要があります. しかし,ピペラシリン治療の最適化には,治療薬のモニタリングが必要である.
科学分野:
- 薬物動力学と薬物動力学
- クリティカル ケア 医療
- 腎臓科
背景:
- 集中治療室 (ICU) の患者の腎臓クリアランスの増加は,ピペラシリンの低暴露と関連しています.
- 腎機能に基づくピペラシリンの最適な投与戦略は,ICUの設定では不明である.
- 以前の研究では,重症患者のピペラシリン濃度が不十分になる可能性があることが示されています.
研究 の 目的:
- 異なる腎機能の公式を用いて,ピペラシリンの過多曝露と過少曝露の予測性を評価する.
- 腎機能が変化するICU患者における標準ピペラシリン療法の適切性を評価する.
- 異なる腎臓クリアランスのグループで治療用濃度に必要な理論的なピペラシリン用量を決定する.
主な方法:
- 159人のICU患者におけるピペラシリンの安定状態濃度 (Css) の遡及分析.
- コッククロフト・ゴールト,MDRD,CKD-EPI 2021の式を用いた腎機能の推定.
- 腎機能の配方とピペラシリン曝露の関連性を評価する受容器操作特性 (ROC) 曲線分析.
主要な成果:
- コッククロフト- ゴールト方程式は,ピペラシリンの暴露不足 (カットオフ値128 mL/ min) と過剰暴露 (カットオフ値81 mL/ min) のわずかに優れた予測値であった.
- クレアチニンクリアランスが60- 90mL/ minから> 160mL/ minに上昇したため,ピペラシリンの暴露不足は23%から88%に増加した.
- 腎機能により理論的なピペラシリン投与量が大幅に増加したが,個体間には大きな変動があった.
結論:
- ピペラシリンの日用量の漸進的な増加は腎機能によって支えられています.
- ピペラシリンの薬理学には個体間での大きな変動があるため,先入観で堅固な用量推薦はできない.
- 治療薬のモニタリングは,ICU患者のピペラシリン治療の最適化に不可欠です.
関連する概念動画
Renal Failure: Dose Adjustments
151
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
151
Factors Affecting Renal Clearance: Renal Impairment
154
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
154
Acute Kidney Injury V: Interprofessional Care
44
Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
44
Acute Kidney Injury IV: Diagnostic Studies and Prevention
57
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
57
Renal Drug Excretion: Effect of Urine pH, Flow Rate, and Drug pKa
265
The pH of urine, the drug's pKa, and the urine flow rate are vital parameters for drug reabsorption and excretion. Urinary pH varies between 4.6 and 8.0 and is influenced by diet, drug intake, and the patient's pathophysiology. It affects a drug's ionization state and reabsorption. For instance, carbohydrate-rich food produces alkaline urine promoting drug excretion, while proteins and certain medications like ascorbic acid lead to acidic urine enhancing reabsorption.
The pKa of a...
The pKa of a...
265
Renal Drug Clearance: Comparison Between Renal Excretion Methods
267
Renal clearance is a critical parameter encompassing kidney filtration, secretion, and reabsorption processes. It is calculated using a specific equation to determine the rate at which the kidneys clear a drug.
Renal clearance is often associated with the renal glomerular filtration rate (GFR), which represents the rate at which plasma is filtered through the glomeruli in the kidney. When drug reabsorption is minimal and there is no active secretion, renal clearance is closely related to the...
Renal clearance is often associated with the renal glomerular filtration rate (GFR), which represents the rate at which plasma is filtered through the glomeruli in the kidney. When drug reabsorption is minimal and there is no active secretion, renal clearance is closely related to the...
267


